ZOLADEX is a Subcutaneous Implant in the Human Prescription Drug category. It is labeled and distributed by Astrazeneca Pharmaceuticals Lp. The primary component is Goserelin Acetate.
Product ID | 0310-0950_46b6a91f-557e-42f6-a4d5-b10705314542 |
NDC | 0310-0950 |
Product Type | Human Prescription Drug |
Proprietary Name | ZOLADEX |
Generic Name | Goserelin Acetate |
Dosage Form | Implant |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2003-05-05 |
Marketing End Date | 2020-05-31 |
Marketing Category | NDA / NDA |
Application Number | NDA019726 |
Labeler Name | AstraZeneca Pharmaceuticals LP |
Substance Name | GOSERELIN ACETATE |
Active Ingredient Strength | 4 mg/1 |
Pharm Classes | Gonadotropin Releasing Hormone Receptor Agonist [EPC],Gonadotropin Releasing Hormone Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Marketing Start Date | 2003-05-05 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA019726 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2003-05-05 |
Marketing End Date | 2020-05-31 |
Ingredient | Strength |
---|---|
GOSERELIN ACETATE | 3.6 mg/1 |
SPL SET ID: | 6bd94a89-f18a-45e5-d0a4-b343a4f0f03d |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0310-0950 | ZOLADEX | Goserelin acetate |
0310-0951 | ZOLADEX | Goserelin acetate |
50090-2027 | ZOLADEX | Goserelin acetate |
50090-3466 | ZOLADEX | goserelin acetate |
70720-950 | ZOLADEX | goserelin acetate |
70720-951 | ZOLADEX | goserelin acetate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ZOLADEX 74588633 1938346 Dead/Cancelled |
Zeneca Limited 1994-10-21 |
ZOLADEX 74324147 1885525 Dead/Cancelled |
Zeneca Limited 1992-10-21 |
ZOLADEX 74010646 1624402 Live/Registered |
IMPERIAL CHEMICAL INDUSTRIES PLC 1989-12-14 |
ZOLADEX 73545833 1402790 Live/Registered |
IMPERIAL CHEMICAL INDUSTRIES PLC 1985-07-01 |